Regardless of the initial trigger (metabolic stress, alcohol, or virus), the disease typically progresses through a multi-step process: simple steatosis to steatohepatitis (MASH/severe ALD), to cirrhosis and HCC
Semaglutide (Ozempic and Wegovy) The FDA prescribing information states plainly that there are no data on the presence of semaglutide in human milk, the effects on the breastfed infant, or the effects on milk production
Vitamina B6
BPC-157 and TB-500 also have strong anti-inflammatory data but work primarily through tissue repair pathways rather than direct inflammatory pathway inhibition
However, as the malignancy progresses, due to difficulties in vascular and immune cell infiltration, more glucose may be converted to lactate through anaerobic glycolysis, leading to its accumulation and potentially promoting tumor progression further